The Oncentra Prostate v4.x for ultrasound‑guided real‑time HDR brachytherapy in men with localised prostate cancer
NICE guidance
Summary (source: NICE)
Reference: MIB16
Type: NICE guidance
Published: 16 December 2014
Issued by: National Institute for Health and Care Excellence (NICE)
Full guidance: Read on nice.org.uk →
The Oncentra Prostate v4.x for ultrasound‑guided real‑time HDR brachytherapy in men with localised prostate cancer is nice guidance MIB16, issued by the National Institute for Health and Care Excellence (NICE), which produces evidence-based recommendations for health and care in England.
Note: NICE guidance is published under a licence that applies to the UK and does not permit republication of the full text. This page provides the reference and a direct link to the official document. Read the full guidance on nice.org.uk →
Document official
Official summary published by the National Institute for Health and Care Excellence (nice.org.uk), last published 16 December 2014. Indicative information for healthcare professionals — refer to the full document. Reference and link only, per NICE licence.